Masonic Cancer Center, University of Minnesota

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

258

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

15 drugs in development

Phase 28

Phase 15

Preclinical4

By Therapeutic Area

top 4

Oncology

737%

Hematology

211%

Infectious Disease

15%

Metabolic & Endocrine

15%

R&D Momentum

68/100

Pipeline Velocity

25/100

Trial Completion Rate

54/100

Pipeline Concentration

33/100

Pipeline Freshness

52/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners
↗Active in Infectious Disease but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 4, 2026

Active, not recruiting

MT2013-31: Allogeneic Hematopoietic Cell Transplantation for Inherited Metabolic Disorders and Severe Osteopetrosis Following Conditioning With Busulfan (Therapeutic Drug Monitoring), Fludarabine +/- ATG

Nov 3, 2026

Recruiting

Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer Engagers

Oct 28, 2026

Recruiting

Tandem Myeloablative Consolidation Therapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma

Oct 24, 2026

Recruiting

HM2024-29: Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)

Earlier

Oct 17, 2026TrialEffect of Kava on Anxiety and Stress in Cancer Survivors

Oct 16, 2026TrialBiomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users

Oct 7, 2026TrialInfusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

Oct 1, 2026TrialTime Toxicity of Cancer: the Time Demands of Cancer-related Activities and Their Impact on Well-being and Quality of Life

4 more events

Sep 30, 2026TrialMT2022-60: A Phase II Study of Pembrolizumab+ BEAM Conditioning Regimen Before Autologous Stem Cell Transplant (ASCT) Followed by Pembrolizumab Maintenance in Patients of Relapsed or Refractory Classic Hodgkin Lymphoma

Sep 24, 2026TrialStudy of Nutraceutical Intervention With High Phenolic Extra Virgin Olive Oil and Curcumin for Neurofibromatosis, Type 1 (NF1)

Sep 18, 2026TrialA Randomized Double Blind Phase II Trial of Restorative Microbiota Therapy (RMT) in Combination With Durvalumab (MEDI4736) and Chemotherapy in Untreated Patients With Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer

Sep 18, 2026TrialLEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer

Details